Prosecutors say that former pharmaceutical executive Martin Shkreli should be sentenced to no less than 15 years in prison for his three securities fraud convictions, a term that would be more than 10 times longer than the maximum Shkreli’s defense team has argued should apply.

Shkreli, 34, was convicted in August of two counts of securities fraud and a related conspiracy charge and was acquitted on five additional counts related to a scheme in which he defrauded investors in two of his hedge funds, eventually paying them back with assets from a pharmaceutical company he founded.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]